Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Lunai Bioworks

Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 23, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist to add human cellular phenotyping to its Parkinson's disease discovery and validation platform. Under the deal, Lunai gains exclusive rights to Tanaist's licensed…
Impact: Lunai Bioworks is the central party, securing exclusive worldwide rights to Tanaist's cellular phenotyping technology to validate its AI-driven Parkinson's subtypes. The deal expands its discovery platform and could enhance its attractiveness to pharmaceutical partners, though near-term financial impact is limited.
Sep 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Lunai Bioworks live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.